UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000036630 |
|---|---|
| Receipt number | R000041726 |
| Scientific Title | Can humanoid robot EMIEW be effective support system for medical staffs? : a prospective controlled study |
| Date of disclosure of the study information | 2019/05/01 |
| Last modified on | 2021/03/17 10:51:19 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Can humanoid robot EMIEW be effective support system for medical staffs? : a prospective controlled study
Acronym
Can humanoid robot EMIEW be effective support system for medical staffs? : a prospective controlled study
Scientific Title
Can humanoid robot EMIEW be effective support system for medical staffs? : a prospective controlled study
Scientific Title:Acronym
Can humanoid robot EMIEW be effective support system for medical staffs? : a prospective controlled study
Region
| Japan |
Condition
Condition
non
Classification by specialty
| Not applicable |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate duty reduction effect for medical workers by using humanoid robot "EMIEW3"
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Changes in Patient Response Time for Admission/Discharge Explanation with or without Support by EMIEW 3
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Other |
Interventions/Control_1
Humanoid robot EMIES3 does the routine explanation instead of medical worker.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 80 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Persons who obtain written consent to participate in the study.
Key exclusion criteria
Persons for whom it is difficult to confirm their intention.
More than one person to explain.
Persons whose research director has determined that inclusion in research is inappropriate.
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Tokuhara |
| Middle name | |
| Last name | Makoto |
Organization
National Center for Global Health and Medicine
Division name
Admission support center
Zip code
162-8655
Address
1-21-1 Toyama Shinjuku-ku Tokyo
TEL
03-3202-7181
mtokuha@hosp.ncgm.go.jp
Public contact
Name of contact person
| 1st name | Tokuhara |
| Middle name | |
| Last name | Makoto |
Organization
National Center for Global Health and Medicine
Division name
Admission support center
Zip code
162-8655
Address
1-21-1 Toyama Shinjuku-ku Tokyo
TEL
03-3202-7181
Homepage URL
mtokuha@hosp.ncgm.go.jp
Sponsor or person
Institute
National Center for Global Health and Medicine
Institute
Department
Personal name
Funding Source
Organization
HITACHI Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
National Center for Global Health and Medicine
Address
1-21-1 Toyama Shinjuku-ku Tokyo
Tel
03-3202-7181
rinrijm@hosp.ncgm.go.jp/ rinrijm@hosp.ncgm.go.jp
Secondary IDs
Secondary IDs
YES
Study ID_1
NCGM-G-003095-01
Org. issuing International ID_1
National Center for Global Health and Medicine
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
国立国際医療研究センター
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 05 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2019 | Year | 03 | Month | 19 | Day |
Date of IRB
| 2019 | Year | 04 | Month | 05 | Day |
Anticipated trial start date
| 2019 | Year | 05 | Month | 13 | Day |
Last follow-up date
| 2020 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
| 2020 | Year | 03 | Month | 31 | Day |
Date trial data considered complete
| 2020 | Year | 03 | Month | 31 | Day |
Date analysis concluded
| 2021 | Year | 03 | Month | 07 | Day |
Other
Other related information
Management information
Registered date
| 2019 | Year | 04 | Month | 30 | Day |
Last modified on
| 2021 | Year | 03 | Month | 17 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041726
